L  CSR Initiatives in Business Processes Astellas is strongly committed to respecting human rights in every stage of its business processes. Furthermore,  we endeavor to ensure compliance with the Pharmaceutical Affairs Act of Japan and other relevant laws and  regulations throughout our value chain, from research and development to the provision of product information. clInIcAl DEVEloPmEnT (P54) GlP GcP GmP N  Protection of human rights, privacy and  confidentiality of personal information of  research subjects, and assurance of reliability in clinical trials N  Ensuring transparency in relationships with  medical institutions in clinical trials N  Disclosure of study information and publication  of study results PRocUREmEnT (P57) The Astellas Value Chain Par tners Suppliers Alliance Partners Contract Research Organizations TEchnoloGy & mAnUFAcTURInG (P56) N  Measures to prevent medical malpractice and to improve the  distinguishability of pharmaceuticals N  Introducing universal design to  product packaging Promote CSR throughout the value chain in collaboration with  business partners N  Ethical considerations in research on human subjects and  specimens derived from humans N  Ethical considerations in animal testing N  Biosafety control N  Handling of intellectual property RESEARch (P54) QUAlITy AnD RElIABIlITy ASSURAncE (REGUlAToRy AFFAIRS (RA), QUAlITy ASSURAncE (QA), Astellas Pharma Inc.  _ Annual Report 2014 52